More results...

logo_oncodesign_services_blanc_couleurs

More results...

Contact
  • Discovery Services
    • Structural Biology
    • Medicinal Chemistry
    • In Vitro biology
    • DMPK
    • Bioanalysis, Formulation, Immunogenicity and Biomarkers
    • Bioconjugation and Radiochemistry Platform
    • In Vivo Pharmacology
    • In Vivo Imaging
  • Oncology
    • Immuno-Oncology
    • Tumor Models
    • Orthotopic Models
    • Metastatic Models
    • Humanized Models
    • Radiopharmaceutical Development
  • Inflammation
    • Autoimmunity Models
    • Dermal Models
    • Endometriosis Models
    • IBD Models
    • Kidney Models
    • Liver Models
    • Lung Models
    • Systemic Inflammation Models
  • Microbiome
  • Resources
  • Join us!
    • Job offers
    • Our HR Policy
  • About us
    • Our history
    • Management
    • Our CSR approach
    • Network
    • News
Contact
  • EXPLORE: Identification and validation of therapeutic targets
  • DRIVE-IDDS: integrated drug discovery solution
  • INPACT: integrated services in preclinical pharmacology
  • SOLO: offers from our innovative technical platforms
  • D-VLOP: bringing your drug to IND filing
Home . [FR] Les Echos – Parkinson : Oncodesign s’allie à Servier pour trouver une thérapie efficace . Page 13

News

Ressources presse
23/03/2014

[FR] Tout sur mes finances – Oncodesign : succès de l’IPO sur Alternext, prix fixé à 7,34 euros

Read more
Ressources presse
23/03/2014

[FR] Tout sur mes Finances – Oncodesign, introduction en Bourse d’une biotech originale

Read more
Ressources presse
18/03/2014

[FR] BFM – Oncodesign souhaite ‘accélérer l’activité de découverte’

Read more
Ressources presse
17/03/2014

[FR] le Journal de Saône-et-Loire – Investir contre le cancer, Oncodesign entre en bourse

Read more
Ressources presse
13/03/2014

[FR] Boursorama – Oncodesign arrive sur Alternext (vidéo)

Read more
Ressources presse
12/03/2014

[FR] Le Figaro – Oncodesign, un modèle à part parmi les biotechs

Read more
Ressources presse
12/03/2014

[FR] La Bourse et la Vie – Philippe Genne interviewé par Didier Testot

Read more
Ressources presse
12/03/2014

[FR] Le Bien Public – Mouvements de fond, Oncodesign augmente son capital

Read more
Ressources presse
11/03/2014

[FR] Capital – Oncodesign, une nouvelle biotech débarque sur Alternext

Read more
Ressources presse
11/03/2014

[FR] Traces écrites – Oncodesign lance aujourd’hui à Dijon son entrée en bourse sur le marché Alternext à Paris

Read more
Ressources presse
10/03/2014

[FR] Boursier – Oncodesign se lance en bourse

Read more
Ressources presse
14/02/2014

[FR] France 3 – La société Oncodesign lance son introduction en Bourse (vidéo)

Read more
1 2 … 12 13 14

Contact-us

20 rue Jean Mazen - FR - 21000 Dijon
Tel.+33 380 788 260

Get in touch

Science within easy reach!

Receive our general news!

Explore Oncodesign Services vitality
logo_oncodesign_services_blanc_couleurs

Follow us

linkedin twitter Stand with Ukraine
  • Discovery Services
    • Medicinal Chemistry
    • In Vitro biology
    • DMPK
    • In Vivo Pharmacology
  • Therapeutic areas
    • Oncology
    • Inflammation
  • Integrated Solutions
    • Small Molecule
    • Molecular Radiotherapy
    • Biologics
  • Legal notice
  • Personal data policy
  • General Terms And Conditions Of Purchase
  • Contact